|
|
|
Insider
Information: |
Dhanak Dashyant |
Relationship: |
|
City: |
Wilmington |
State: |
DE |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
217,143 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$7,378,474 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
217,143 |
|
|
Total
Value |
$7,378,474 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
EVP & Chief Scientific... |
2023-07-14 |
58,968 |
2018-12-10 |
0 |
Premium* |
|
Deciphera Pharmaceuticals, Inc. |
DCPH |
|
2024-02-15 |
158,175 |
2023-09-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2018-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,878 |
6,878 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2019-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,761 |
13,639 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2020-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,881 |
19,987 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2020-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,661 |
26,648 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2020-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,232 |
29,242 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2021-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,853 |
34,002 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,678 |
42,142 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2022-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,274 |
53,416 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2023-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,980 |
55,682 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2023-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
8,056 |
58,968 |
0 |
- |
|
DCPH |
Deciphera Pharmaceuticals... |
EVP & Chief Scientific Officer |
|
2023-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
140,900 |
140,900 |
0 |
- |
|
DCPH |
Deciphera Pharmaceuticals... |
EVP & Chief Scientific Officer |
|
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,275 |
158,175 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2021-10-01 |
4 |
AS |
$68.67 |
$26,713 |
D/D |
(389) |
31,263 |
0 |
% |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2021-09-01 |
4 |
AS |
$76.71 |
$29,763 |
D/D |
(388) |
31,652 |
0 |
% |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2021-08-02 |
4 |
AS |
$77.49 |
$30,144 |
D/D |
(389) |
32,040 |
0 |
% |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2021-03-01 |
4 |
AS |
$79.73 |
$31,493 |
D/D |
(395) |
27,732 |
0 |
% |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2021-06-01 |
4 |
AS |
$84.13 |
$33,231 |
D/D |
(395) |
26,545 |
0 |
% |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2021-05-03 |
4 |
AS |
$85.40 |
$33,818 |
D/D |
(396) |
26,940 |
0 |
% |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2021-12-10 |
4 |
D |
$65.40 |
$34,858 |
D/D |
(533) |
33,464 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2022-12-12 |
4 |
D |
$82.36 |
$43,898 |
D/D |
(533) |
50,702 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2019-12-10 |
4 |
D |
$95.72 |
$51,019 |
D/D |
(533) |
13,106 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2020-12-10 |
4 |
D |
$82.05 |
$59,076 |
D/D |
(720) |
28,522 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2020-05-06 |
4 |
OE |
$65.42 |
$62,869 |
D/D |
961 |
20,948 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2020-06-08 |
4 |
OE |
$65.42 |
$62,869 |
D/D |
961 |
20,948 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Scientific Officer |
|
2020-07-06 |
4 |
OE |
$65.42 |
$62,869 |
D/D |
961 |
26,552 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|